TOKYO, December 18, 2025 /PRNewswire/ — Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, in partnership with Hitachi High-Tech Corporation (HHT), announces the presentation of high-resolution structural variation data on the OhmX(™) at the annual meeting of the Japanese Society of Human Genetics (JSHG) to be held on December 17-20, 2025 in Yokohama, Japan.
In partnership with Dr. Catherine Brownstein, MPH, Ph.D. of Boston Children’s Hospital, Nabsys and HHT will host a lunch seminar on Thursday, December 18, 2025 from 12:25 p.m. to 1:25 p.m. at the Yokohama Conference Center (3F, Room 304). Participants will hear about advances in structural variant analysis with electronic genome mapping (EGM) from speakers Dr. Tadashi Kaname of the Department of Genomic Medicine Research, National Center for Health and Development, Edd Lee, global vice president of sales and marketing, Nabsys, and Dr. Catherine Brownstein, scientific director of the Manton Center Gene Discovery Core; Research Associate, Division of Genetics and Genomics; Deputy Director, Molecular Genetics Core; and assistant professor at Harvard Medical School.
The data presented demonstrates the use of EGM technology in a tertiary children’s hospital and research center, and how the OhmX platform works in symphony with a comprehensive multi-omics strategy to accelerate rare disease gene discovery.
Dr. Brownstein, MPH, Ph.D., Boston Children’s Hospital noted, “Nabsys’ EGM technology, which provides high-resolution genome-wide analysis of structural variation, has allowed us to gain insight into previously undetectable structural variations and has thus become a crucial tool for understanding the underlying etiology of particularly rare or difficult-to-diagnose diseases.
In addition to the luncheon, Nabsys and Hitachi High-Tech America, Inc. (HTA) will present a scientific poster on “High-Resolution Detection of TP53 Deletions using Electronic Genome Mapping” describing the effectiveness of EGM when applied to cancer genomics.
Title: High-resolution detection of TP53 deletions using electronic genome mapping
Presenter: Shuk Shukor, Hitachi High-Tech America, Inc.
Abstract number: P3-02-14
Session: Poster Session 3-02 “Cancer Genetics 3”
Date/time: December 20, 2025, 2:20 p.m. – 3:20 p.m. (JST)
“We are pleased to present a wide range of new and important research at this year’s JSHG meeting that illuminates the real-world impact of our product, the OhmX platform, on researchers,” said Barrett Bready, MD, founder and CEO of Nabsys. “The lunch seminar and our research highlight the importance of speed, accessibility, and accuracy in whole-genome structural variation research, and we are proud to share additional data that demonstrates how our platform has revolutionized genome mapping.”
About Nabsys 2.0, LLC
Nabsys is advancing genomics with a clear focus on accessibility and innovation through its proprietary electronic genome mapping (EGM) technology. Implemented on OhmX Platform™, EGM integrates precision electronics, nanofluidics and computational biology to provide high-resolution information on genome structure. This approach expands the possibilities for research in cytogenetics, molecular genetics, and cell and gene therapy, while providing comprehensive analysis of structural variations to laboratories of all sizes. The company was founded in 2005 and is based in Providence, Rhode Island. For more information, visit www.nabsys.com.
About Hitachi High-Tech Corporation
Hitachi High-Tech provides cutting-edge technologies, products and services to the company and its customers with its corporate vision “Change the world and the future with the power of knowledge” to contribute to a sustainable global environment, healthy, safe and secure lives, and the sustainable development of science and industry. We manufacture and sell clinical analyzers, biotechnology products and radiotherapy systems in the healthcare field, semiconductor manufacturing and inspection equipment in the semiconductor field, and analytical systems and electron microscopes used in environmental fields and materials research. We are also engaged in a wide range of business areas globally, providing high value-added solutions in the areas of batteries, communications infrastructure, railway inspection, digital and other industrial and social infrastructure areas. By deeply understanding the issues facing society and our customers and using installed base (digital assets) and domain knowledge, we deliver digital services through Lumada 3.0, enhanced by AI. Along with Inspire 2027, the Hitachi Group’s new management plan, we are helping to achieve a harmonized society where the environment, well-being and economic growth coexist in harmony. The company’s consolidated revenues for FY2024 were approx. 756.5 billion JPY.
For more information, visit https://www.hitachi-hightech.com/global/en/
Media contact
David Rosen
Partners Slang
David.rosen@argotpartners.com
646-461-6387
Show original content:^ https://www.prnewswire.com/apac/news-releases/nabsys-and-hitachi-present-electronic-genome-mapping-data-at-japanese-society-of-human-genetics-jshg-2025-annual-meeting-302645056.html
SOURCE Absys
